Clinical Trial Update: Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study [Phase 2]

View source ↗

Summary

A Phase II study evaluated Abraxane in combination with Avastin in patients with metastatic malignant melanoma, with results posted after trial completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Avastin (bevacizumab)

Snippet

Sponsor: Lynn E. Spitler, MD | Conditions: Metastatic Malignant Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2014-01-08